SCHEMBL3088134

SCHEMBL3088134

Clc1ccc2nc(N3CCCNCC3)oc2c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SOS1 Q07889 1/20 0.56
HRH4 Q9H3N8 2/20 0.49
HTR6 P50406 3/20 0.48
GPR119 Q8TDV5 2/20 0.47
HTR3E A5X5Y0 1/20 0.47
HTR3B O95264 1/20 0.47
HTR3A P46098 1/20 0.47
HTR3D Q70Z44 1/20 0.47
HTR3C Q8WXA8 1/20 0.47
CHRNA1 P02708 1/20 0.44
CHRNB2 P17787 1/20 0.44
CHRNA7 P36544 1/20 0.44
CHRNA4 P43681 1/20 0.44
PIK3CG P48736 1/20 0.43
KDM4E B2RXH2 1/20 0.43
S1PR2 O95136 1/20 0.43
LMNA P02545 1/20 0.43
KMT2A Q03164 1/20 0.43
HIF1A Q16665 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3104207 0.95 SOS1 (0.61) SOS1HRH4HTR6GPR119HTR3E
SCHEMBL3082150 0.90 PTGES (0.53) HRH4HTR6HTR3EHTR3BHTR3A
SCHEMBL3101725 0.83 HTR3E (0.55) HTR6HTR3EHTR3BHTR3AHTR3D
SCHEMBL221216 0.81 ELANE (0.51) HTR6HTR3ACHRNB2CHRNA7CHRNA4
SCHEMBL3072495 0.80 PIK3CG (0.44) SOS1GPR119PIK3CGPTGESPTGS2
SCHEMBL6010830 0.80 PTGES (0.50) SOS1HRH4HTR6GPR119CHRNA1
SCHEMBL21154013 0.79 NPC1 (0.50) SOS1GPR119PIK3CGKDM4EKMT2A
SCHEMBL31349365 0.78 HTR6 (0.52) HTR6GPR119KDM4EKMT2A
SCHEMBL8513477 0.78 HTR6 (0.52) SOS1HTR6GPR119
SCHEMBL3081079 0.77 HTR6 (0.49) HTR6GPR119HTR3AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100261708-A1 Diazepane Compounds Which Modulate The CB2 Receptor BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-10-14 US disclosed
US-20100261708-A1 Diazepane Compounds Which Modulate The CB2 Receptor BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-10-14 US disclosed
US-20100261708-A1 Diazepane Compounds Which Modulate The CB2 Receptor BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-10-14 US disclosed
WO-2009055357-A1 DIAZEPANE COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-04-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100261708-A1 Diazepane Compounds Which Modulate The CB2 Receptor CNR1, CNR2, BDKRB2 SOS1 2565/4885HRH4 107/4885HTR6 345/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.